these buywatches.is have attracted thousands of watch addicts.

Embracing Faith
of a Century

A strong hue symbolising loyalty, strength, wisdom and trust centred with another powerful source that denotes a top view of a savings jar where every investment is a form of an asset.

Common and simplified norms for processing investor's service request by rtas and norms for furnishing pan, kyc details and nomination

SEBI Circular dated November 03, 2021

FORM ISR-1

FORM ISR-2

FORM ISR-3

FORM SH-13

FORM SH-14

Annual

For the year ended 2021-22

MGT 7 (FY 2021-22)

44th AGM – Proceedings

44th AGM – Consolidated Scrutiniser Report

Newspaper Publication – 44th AGM 

Annual Report 2021-22     

Annual Secretarial Compliance Report 2021-22

For the year ended 2020-21

MGT 7 (FY 2020-21)

Voting Results 43rd AGM

Outcome – 43 AGM

Annual Report 2020-21

For the year ended 2019-20

MGT 7 (FY 2019-20)

MGT 9

Outcome of 42 AGM

Voting Result of 42st AGM

Annual Report 2019-20

For the year 2018-19

Outcome of 41st AGM

Voting Result of 41st AGM

Annual Report 2018 – 19

Book Closure

Book Closure 2018

Secretarial Compliance Report

Quarterly

For the quarter ended on 31.12.2022

Newspaper Publication

Unaudited Financial Results along with LRR

Compliance Certificate 74 (5) 31.12.2022

Reconciliation of Share Capital 31.12.2022

Corporate Governance 31.12.2022

Shareholding Pattern 31.12.2022

For the quarter ended on 30.09.2022

Newspaper Publication

Unaudited Financial Results (Consolidated and Standalone) along with LRR         

Compliance Certificate 74 (5) 30.09.2022

Reconciliation of Share Capital 30.09.2022

Corporate Governance 30.09.2022

Shareholding Pattern 30.09.2022

For the quarter ended on 30.06.2022

Newspaper Publication

Unaudited Financial Results (Consolidated and Standalone) along with LRR 

Corporate Governance 30.06.2022

Reconciliation of Share Capital 30.06.2022

Shareholding Pattern 30.06.2022

For the quarter ended on 31.03.2022

Newspaper Publication

Audited Financial Result 31.03.2022

Compliance Certificate 74(5) 31.03.2022

Reconciliation of Share Capital 31.03.2022

Corporate Governance 31.03.2022

Shareholding Pattern 31.03.2022

For the quarter ended on 31.12.2021

Unaudited Financial Results along with LRR

Compliance Certificate 74 (5) 31.12.2021

Reconciliation of Share Capital 31.12.2021

Corporate Governance 31.12.2021

Shareholding Pattern 31.12.2021

For the quarter ended on 30.09.2021

Unaudited Financial Results (Consolidated and Standalone) along with LRR

Compliance Certificate 74 (5) 30.09.2021

Reconciliation of Share Capital 30.09.2021

Corporate Governance 30.09.2021

Shareholding Pattern 30.09.2021

For the quarter ended on 30.06.2021

Newspaper Publication

Compliance Certificate 74(5) 30.06.2021

Corporate Governance 30.06.2021

Shareholding Pattern 30.06.2021

Result-11.08.2021

For the quarter ended on 31.03.2021

Newspaper Publication

Audited financial Result (Consolidated and Standalone) along with Auditors Report 31.03.2021

Shareholding Pattern_31.03.2021

Corporate Governance 31.03.2021

Reconciliation of Share Capital 31.03.2021

Compliance Certificate 74 (5) 31.03.2021

For the quarter ended on 31.12.2020

Shareholding Pattern

Corporate Governance

Reconciliation Share Capital

Compliance Certificate Under Reg 74-5

Unaudited Financial Results along with LRR

For the quarter ended on 30.09.2020

Shareholding Pattern

Corporate Governance Report

Reconciliation of Share Capital Audit Report

Unaudited Financial Results (Consolidated and Standalone) along with LRR

For the quarter ended on 30.06.2020

Corporate Governance Report

Reconciliation of Share Capital Audit Report

Unaudited Financial Results (Consolidated and Standalone) along with LRR

Shareholding Pattern 30.06.2020

For the quarter ended on 31.03.2020

Audited financial Result (Consolidated and Standalone) along with Auditors Report 31.03.2020

Reconciliation of Share Capital Audit Report ASE 31.03.2020

Shareholding Pattern ASE 31.03.2020

Regulation 74(5) RTA 31.03.2020

Corporate Governance_ASE_ 31.03.2020

For the quarter ended on 31.12.2019

Unaudited Financial Result (Consolidated and Standalone) along with LRR

Reconciliation of Share Capital Audit Report 31.12.2019

Compliance Certificate U/r. 74(5) for 31.12.2019

Corporate Governance 31.12.2019

Shareholding 31.12.2019

For the quarter and half year ended on 30.09.2019

Unaudited Financial Result (Consolidated and Standalone) along with LRR

Shareholding 30.09.2019

Corporate Governance 30.09.2019

Statement of Investors Complaints 30.09.2019

Reconciliation of Share Capital Audit Report

Certificate Under Regularisation 40(9)

For the quarter ended on 30.06.2019

Corporate Governance Report

Shareholding Pattern

Reconciliation of Share Capital Audit Report

Unaudited Financial Result

(Consolidated and Standalone) along with LRR

For the quarter ended on 31.03.2019

Corporate Governance Report

Shareholding Pattern

Reconciliation of Share Capital Audit Report

Audited Financial Result

Audited Financial Result

For the quarter ended on 31.12.2018

Unaudited Fin Result

For the quarter ended on 30.09.2018

Unaudited Fin Result

For the quarter ended on 30.06.2018

Unaudited Fin Result

For the quarter ended on 31.03.2018

Auditors Report

Audited Fin Result

Board Meeting

Notice

Notice 30.05.2023

Notice – 10.02.2023

Notice – 9.11.2022

Notice – 10.08.2022

Notice – 26.05.2022

Notice – 14.02.2022

Notice – 13.11.2021

Notice – 11.08.2021

Notice – 04.06.2021

Notice – 12.02.2021

Notice – 10.11.2020

Notice – 20.08.2020

Notice – 22.07.2020

Notice – 22.07.2020

Notice – 14.11.2019

Notice – 13.08.2019

Notice – 29.05.2019

Notice – 12.02.2019

Notice – 13.11.2018

Notice – 14.08.2018

Notice – 25.05.2018

Outcome

Outcome BM – 30.05.2023

Outcome BM – 10.02.2023

Outcome BM – 9.11.2022

Outcome BM – 10.08.2022  

Outcome BM – 26.05.2022

Outcome BM – 14.02.2022

Outcome BM – 13.11.2021

Outcome BM – 11.08.2021

Outcome BM 04.06.2021 Final

Outcome BM 12.02.2021

Outcome BM 02.01.2021

Outcome BM 10.11.2020

Outcome BM 20.08.2020

Outcome -22.07.2020

Outcome of Meeting – 14.11.2019

Outcome – 13.08.2019

Outcome – 29.05.2019

Outcome – 12.02.2019

Outcome – 13.11.2018

Outcome – 14.08.2018

Outcome – 25.05.2018

Miscellaneous

New Product Launch by Cosara

Closure of Trading window 31.03.2023

Closure of Trading window 31.12.2022

Closure of Trading Window 30.09.2022  

Closure of Trading window 30.06.2022

Closure of Trading Window 31.03.2022

Closure of Trading Window 31.12.2021

Closure of Trading Window 30.09.2021

Closure of Trading Window 30.06.2021

Synbiotics

COSARA

Bse Updates on Cosara

Closure of Trading Window 30.09.2019

Certificate under regulation 74(5)

Closure of Trading Window

SAST

Non Applicability of LC

Others

Newspaper Publication 01.06.2023

Familiarization Programme of Independent Directors imparted Corporate Information and Composition

Terms and Conditions of Appointment of ID

Shareholding Pattern 31.03.2023

Corporate Governance 31.03.2023

Reconciliation of Share Capital 31.03.2023

Compliance Certificate 74 (5) 31.03.2023

Corporate Information

Code of Fair Disclosure of Unpublished Price Sensitive Information

Sexual Harassment Policy

Familiarisation Programme of Independent Directors

Annual Evaluation

Board Diversity Policy

Policy For Determining Material Subsidiaries

Whistle Blower Policy

Policy on Materiality events

Related Party Transactions Policy

Policy on Preservation of Documents (Archival Policy)

NRC Policy

Reply to Clarification sought by BSE dated 05.12.2019

Mgt-9

Code of Conduct

Voting Result

Financials - Subsidiaries

Systronics India Ltd. Financials 2021-22

Synbiotics Ltd. Financials 2021-22

Swetsri Investments Pvt. Ltd. Financials 2021-22

Sarabhai M. Chemicals Ltd. Financials 2021-22

Asence Pharma Pvt. Ltd. Financials FY 2021-22

Systronics India Limited Financials 2020-21

Synbiotics Limited Financials 2020-21

Swetsri Investmetns Pvt. Ltd. Financials 2020-21

Suvik Hitek Pvt. Ltd. Financials 2020-21

Sarabhai M Chemicals Ltd. Financials 2020-21

Sarabhai Chemicals India Pvt. Ltd. Financials 2020-21

Asence Pharma Pvt. Ltd. Financials 2020-21

ASE Office at Ahmedabad